TNF receptor-associated periodic syndrome (TRAPS): A new cause of joint destruction?

Joint Bone Spine

Volumn 76, Issue 5, 2009, Pages 567-569

  Schoindre, Yoland ^a   Feydy, Antoine ^a   Giraudet Lequintrec, Janine Sophie ^a   Kahan, André ^a   Allanore, Yannick ^a  

^a Institut Cochin   (France)

Author keywords

Autoinflammatory syndrome; Etanercept; Joint erosions

Indexed keywords

C REACTIVE PROTEIN; ETANERCEPT; GLUCOCORTICOID; METHOTREXATE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR RECEPTOR 1;

ABDOMINAL DISEASE; AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; BLOOD TESTIS BARRIER; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; JOINT DESTRUCTION; LABORATORY TEST; LEUKOCYTOSIS; LYMPHANGITIS; MAINTENANCE THERAPY; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SKIN DISEASE; SYNOVITIS; TENOSYNOVITIS; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; VASCULITIS; WRIST;

AGED; ANKLE JOINT; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INFLAMMATION; JOINT DISEASES; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; WRIST JOINT;

EID: 70449701478     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.08.002     Document Type: Article

References (15)

1. Hull K.M., Drewe E., Aksentijevich I., et al. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81 (2002) 349-368
2. McDermott M.F., Aksentijevich I., Galon J., et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97 (1999) 133-144
3. INFEVERS: an online database for autoinflammatory mutations. Copyright. Available at http://fmf.igh.cnrs.fr/ISSAID/infevers/.
4. Dodé C., André M., Bienvenu T., et al. The enlarging clinical, genetic, and population spectrum of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome. Arthritis Rheum 46 (2002) 2181-2188
5. Stankovic K., and Grateau G. Auto inflammatory syndromes: Diagnosis and treatment. Joint Bone Spine 74 (2007) 544-550
6. D'Osualdo A., Ferlito F., Prigione I., et al. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum 54 (2006) 998-1008
7. Lobito A.A., Kimberley F.C., Muppidi J.R., et al. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108 (2006) 1320-1327
8. Ravet N., Rouaghe S., Dodé C., et al. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamiliy 1A gene. Ann Rheum Dis 65 (2006) 1158-1162
9. Rebelo S.L., Bainbridge S.E., Amel-Kashipaz M.R., et al. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum 54 (2006) 2674-2687
10. Nowlan M.L., Drewe E., Bulsara H., et al. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology (Oxford) 45 (2006) 31-37
11. Churchman S.M., Church L.D., Savic S., et al. A novel TNFRSF1A splice mutation associated with increased NF-κB transcription factor activation in patients with TNF-receptor associated periodic syndrome (TRAPS). Ann Rheum Dis 2008 67 (2007) 1589-1595
12. Pétrilli V., and Martinon F. The inflammasome, autoinflammatory diseases, and gout. Joint Bone Spine 74 (2007) 571-576
13. Drewe E., and Powell R.J. Novel treatment for tumour necrosis factor receptor associated periodic syndrome (TRAPS): case history of experience with infliximab and sirolimus post etanercept. Clin Exp Rheumatol 20 suppl 26 (2002) S71 [abstract]
14. Drewe E., McDermott E.M., Powell P.T., et al. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford) 42 (2003) 235-239
15. Simon A., Bodar E.J., van der Hilst J.C., et al. Beneficial response to interleukin 1 receptor antagonist in TRAPS. Am J Med 117 (2004) 208-210 [letter]